Polymerase Chain Reaction Market by Product (Consumables & Reagents, Instruments, Software & Services), Technology (Digital PCR, Real-time PCR, Traditional PCR), Application, End-User - Global Forecast 2024-2030

Polymerase Chain Reaction Market by Product (Consumables & Reagents, Instruments, Software & Services), Technology (Digital PCR, Real-time PCR, Traditional PCR), Application, End-User - Global Forecast 2024-2030

The Polymerase Chain Reaction Market size was estimated at USD 9.08 billion in 2023 and expected to reach USD 10.20 billion in 2024, at a CAGR 12.57% to reach USD 20.82 billion by 2030.

Global Polymerase Chain Reaction MarketPolymerase chain reaction (PCR) is a increasingly used technique in modern biology for in-vitro amplification and generating several copies of a specific region in a DNA strand. Increasing research and development (R&D) activities in advanced molecular biology and forensic science, rising demand for personalized medicines, and advancement in genetic engineering are projected to drive the demand for polymerase chain reaction instruments. The demand for polymerase chain reaction systems is increasing in the food industry to detect pathogenic microorganisms and identify allergens. However, the high cost and technical limitations associated with polymerase chain reaction impede the market's growth. The introduction of highly sensitive and optimized polymerase chain reaction instruments by market vendors is expected to fuel the market's growth.Regional InsightsThe Americas represents a highly developing and innovative landscape for the global polymerase chain reaction market characterized by rising awareness and market players' increasing introduction of advanced polymerase chain reaction systems. In August 2022, GenScript USA launched a real-time polymerase chain reaction (RT-PCR) monkeypox test for research lab use. Significant governmental initiatives and investments to expand biotechnology research and development with advanced analytical equipment are expected to foster the growth of the polymerase chain reaction market. In May 2021, the Australian Government committed USD 206.4 million to a patent box tax incentive scheme to encourage investment in Australia's biotechnology and medical technology sectors. Asia's vast population, focus on investments in specialized clinical trial centers, and government support for clinical trials are significant factors in the region's reputation as a hub for successful clinical trials. The polymerase chain reaction market witnessed substantial growth in Europe, the middle east, and African (EMEA) regions owing to the ongoing development of the life science industry. According to the United Kingdom Government, the country's healthy life science sector contributes more than USD 66 billion and 220,000 jobs annually to the UK economy.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Polymerase Chain Reaction Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Polymerase Chain Reaction Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Polymerase Chain Reaction Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., 3M Company, Abbott Laboratories, ACON Laboratories, Inc., Agilent Technologies, Inc., Azure Biosystems Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMérieux, S.A., Danaher Corporation, Eppendorf SE, F. Hoffmann-La Roche Ltd., Fluidigm Corporation, GeneCopoeia, Inc., Illumina, Inc., JN Medsys Pte. Ltd., Kawasaki Heavy Industries, Ltd., KYORIN Pharmaceutical Co., Ltd., LabTurbo Biotech Corporation, LGC Limited, MBS Molecular Biology Systems, Merck KGaA, Microsynth AG, Molbio Diagnostics Pvt. Ltd., Ningbo Scientz Biotechnology Co., Ltd., Promega Corporation, Shimadzu Corporation, Siemens AG, Standard BioTools, Stilla Technologies, Stilla Technologies Inc., SV SCIENTIFIC PRIVATE LIMITED, Sysmex AG, Takara Bio Inc., Thermo Fisher Scientific, Inc., and VWR International, LLC by Avantor, Inc..

Market Segmentation & Coverage

This research report categorizes the Polymerase Chain Reaction Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
Consumables & Reagents
Instruments
Software & Services
Technology
Digital PCR
Real-time PCR
Traditional PCR
Application
Medical
Clinical
Blood screening
Oncology testing
Pathology testing
Forensics
Research
Non-Medical
Agriculture
Food
End-User
Academic Research Institutes
Biotechnology Companies
Contract Research Organization/ Contract Manufacturing Organization
Diagnostic Laboratories
Hospitals
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Polymerase Chain Reaction Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Polymerase Chain Reaction Market?
3. What are the technology trends and regulatory frameworks in the Polymerase Chain Reaction Market?
4. What is the market share of the leading vendors in the Polymerase Chain Reaction Market?
5. Which modes and strategic moves are suitable for entering the Polymerase Chain Reaction Market?

Note: PDF & Excel + Online Access - 1 Year